相关实验视频

Updated: Jan 9, 2026

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

来自发酵饮料的生物活性阿波芬和黄类药物向肥胖和2型糖尿病的代谢炎症途径

Xiurong Wu¹, Yang Qiu¹, Rui Dai¹

¹School of Food and Health, Guilin Tourism University, Guilin, China.

Scientific reports

|December 8, 2025

概括

FH03FS是一种来自药用植物的发酵饮料,含有针对肥胖和2型糖尿病 (T2D) 的阿波芬和黄类. 这项研究为其作为功能性食品干预的潜力提供了植物化学和机械学的基础.

科学领域:

植物化学植物化学
营养科学营养科学
药理学药理学是指药理学的学科.

背景情况:

全球肥胖和2型糖尿病 (T2D) 的增长需要新的饮食干预措施.
来自五种药用食品同类植物 (MFH) 的发酵饮料FH03FS是潜在的候选者,但缺乏植物化学和机械特征.

研究的目的:

为了描述FH03FS的植物化学概况.
阐明其潜在有效性背后的多目标机制,以消除肥胖和T2D.
为FH03FS作为功能性饮料提供科学基础.

主要方法:

超高性能液体色谱-并联质谱 (UPLC-MS/MS) 用于植物化学分析.
在 silico ADMET 分析和网络药理学,以获得机械洞察力.
分子对接和分子动力学 (MD) 模拟用于目标相互作用验证.

主要成果:

FH03FS含有多种化合物,其中阿波芬和黄类化合物被确定为主要生物活性成分.
在分析预测了有利的药理动力学,低毒性和代谢炎症途径的调节.
分子模拟证实了摩林和阿西米洛宾等化合物与关键标 (ESR1,PPARG) 之间的高亲和相互作用.

结论:

富含阿波芬和黄类的FH03FS具有对肥胖和T2D有益的多目标效应.
这项研究为FH03FS的发展奠定了植物化学和机械学的基础.
这些发现为未来对这种功能饮料的临床验证提供了可测试的假设.

关键词:

亚氨酸是一种亚氨酸.黄类化合物黄类化合物功能性饮料是一种功能性饮料.分子动态模拟分子动态模拟肥胖问题肥胖问题 2 型糖尿病 2 型糖尿病

更多相关视频

Rapid Model to Evaluate the Anti-Obesity Potential of a Combination of Syzygium aromaticum Clove and Cuminun cyminum Cumin on C57BL6/j Mice Fed High-Fat Diet

Rapid Model to Evaluate the Anti-Obesity Potential of a Combination of Syzygium aromaticum Clove and Cuminun cyminum Cumin on C57BL6/j Mice Fed High-Fat Diet

Published on: July 31, 2021

Extraction and Analysis of Taiwanese Green Propolis

Extraction and Analysis of Taiwanese Green Propolis

Published on: January 7, 2019

相关概念视频

Glucagon-like Receptor Agonists

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...

Microbial Fermentation

Microbial Fermentation

Fermentation is a crucial anaerobic metabolic process that enables microbes to derive energy from sugar without relying on oxygen or an electron transport chain. This process is fundamental to various biological and industrial applications and is classified based on the metabolic products generated.Role of Pyruvate in FermentationPyruvate and its derivatives serve as key electron acceptors in fermentative pathways. The oxidation of NADH to regenerate NAD+ is essential for the continuation of...